Sabinsa Gains U.S. Patent for Cococin

April 16, 2008

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal

PISCATAWAY, N.J.Sabinsa Corp. was awarded a new U.S. patent (No. 7,300,682), Method of preparation and use of coconut water in mamalian tissue nourishment growth and healthy maintenance. The patent covers the derivation process, composition and intended uses of Sabinsas branded ingredient Cococin, a freeze-dried powder form of green coconut water.

Coconut waters staggering levels of active ingredients provides an exceptionally rich repository of vitamins, minerals and amino, shikimic and quinic acids essential for healthy tissue growth, resulting in an optimal ingredient for todays cosmeceutical market, said Lakshmi Prakash, Ph.D., vice president of innovation and business development at Sabinsa. We have worked diligently to secure this process, composition and use patent to ensure a safe and efficacious ingredient resulting from Sabinsas high-quality, nutrient-preserving freeze drying process.

In addition to the new U.S. patent, Cococin is covered by a European Patent (No. EP1341547) for its process, composition and use in the European market.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like